Immucell (ICCC) EPS (Basic) Growth (1y) (2011 - 2026)
Powered by 
Analysis
Immucell (ICCC) EPS (Basic) Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 39.99 Bn | 39.79 Bn | 779.09 Mn | 17.24% |
| 2 | Zoetis | 30.50 Bn | 28.83 Bn | 1.05 Bn | 1.21% |
| 3 | Elanco Animal Health | 11.44 Bn | 10.91 Bn | 798.00 Mn | 388.06% |
| 4 | Phibro Animal Health | 1.48 Bn | 1.40 Bn | 134.40 Mn | 73.95% |
| 5 | Immucell | 89.38 Mn | 80.52 Mn | 2.44 Mn | 264.21% |
| 6 | Zhengye Biotechnology Holding | 74.34 Mn | 67.24 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 5.44% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 264.21% |
| Dec 31, 2025 | -343.20% |
| Sep 30, 2025 | 82.02% |
| Jun 30, 2025 | 128.34% |
| Mar 31, 2025 | 385.21% |
| Dec 31, 2024 | 1,109.68% |
| Sep 30, 2024 | 29.17% |
| Jun 30, 2024 | -10.11% |
| Mar 31, 2024 | 81.10% |
| Dec 31, 2023 | 106.72% |
| Sep 30, 2023 | -43.49% |
| Jun 30, 2023 | -43.97% |
| Mar 31, 2023 | -414.50% |
| Dec 31, 2022 | -1,240.56% |
| Sep 30, 2022 | -543.04% |
| Jun 30, 2022 | -771.39% |
| Mar 31, 2022 | 255.45% |
| Dec 31, 2021 | 344.05% |
| Sep 30, 2021 | 142.64% |
| Jun 30, 2021 | 117.35% |